• 

  Mylan launches generic version of Remdesivir in India for COVID-19 patients

  Business | Jul 20, 2020, 02:46 PM IST

  Pharma major Mylan on Monday said it has commercially launched the generic version of Remdesivir drug under the brand name 'Desrem' in India for treatment of coronavirus patients. 

• 

  USFDA accepts proposed biosimilar application by Mylan, Biocon for review

  Business | Mar 09, 2020, 12:51 PM IST

  The US Food and Drug Administration (USFDA) has accepted biologics license application by Mylan and Biocon for proposed biosimilar to Bevacizumab for review, according to a regulatory filing.

• 

  Mylan's Rs 5,168-cr proposal to acquire Agila cleared

  Aug 28, 2013, 10:04 AM IST

  New Delhi: The Foreign Investment Promotion Board (FIPB) has cleared US-based pharmaceutical firm Mylan Inc's Rs 5,168 crore proposal to acquire Indian generic drugs company Agila Specialties.The proposal will now have to be approved by

Advertisement